notice inviting e-tender for procurement of some drug items under table-a, for two years from the date of aoc. , afatinib tab 20 mg , afatinib tab 30 mg , amoxicillin 200mg with clavulanic acid 28.5mg / 5ml syrup i.p , amoxicillin 250mg with clavulanic acid 125 mg tab. , amoxicillin 500mg + clavulanic acid 125mg tab , amoxicillin cap i.p 500 mg , aprepitant tab/cap 125/80/80 combiblister pack , bevacizumab 100mg inj. , bevacizumab inj. 400mg/vial , cefotaxime sodium inj. i.p. 1gm/vial , cefotaxime sodium powder for inj. i.p. 250mg / vial , ceftriaxone inj. b.p. 250mg vial. , ciprofloxacin inj. i.p. 2mg/ml , clindamycin ointment 1% , dextrose inj.i.p. 25% in 100 ml bot. , dextrose solution inj. i.p. 5% (flow, fill & seal process) , dolutegravir ip 50 mg scored tab , erlotinib tab 100 mg , fluticasone propionate cream 0.05% w/w , glimipride 4 mg tab , hydroxyzine ip syrup 10mg/5 ml , lopinavir ip 200 mg + ritonavir ip 50 mg scored tab , luliconazole cream 1% w/w , meropenam inj. 125mg./vial. , metronidazole infusion i.p. 5 mg / ml.- bot. of 100ml , oflxacin infusion 200mg/100ml , permithrin 5% lotion , ringer lactate solution inj. i.p. (flow, fill & seal process) , salicylic acid 12% oint. , salicylic acid 6% oint. , sodium chloride & dextrose injection i.p. (form, fill & seal process) , sodium chloride inj. ip 0.9% (normal or istonic saline) na+154mmol/l,cl-154 mmol/l(ffs process) , tenecteplase 20mg inj / vial ( recombinant tissue plasminogen activator-tnk-tpa inj. 20 mg) , tenofovir ip 300 mg + lamivudine ip 300 mg scored tab , important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender. 2. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 3. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b)in case of sole manufacturer/importer (i.e. proprietary in nature). 4. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis. 5. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).